Article,

Randomized study of the effect of antenatal dexamethasone on growth and development of premature children at the corrected age of 2 years.

, , , , , and .
Acta Paediatr, 86 (3): 294--298 (March 1997)

Abstract

The objective of the series was to study the effect of prenatal dexamethasone therapy on the growth and neurological development of preterm children until the age of 2 years. Eighty-two children with a mean gestational age of 30 (24-33) weeks and a mean weight of 1291 (530-2360) g at birth, treated antenatally with either dexamethasone (n = 50) or placebo (n = 32), were examined at the adjusted age of 24 months by a paediatric neurologist, a neuropsychologist and a speech therapist. Neurological development was defined as normal if all scores of neuropaediatric, neuropsychological and verbal tests were within the normal range. Normal neurological development was found in 52\% of the dexamethasone-treated and in 34\% of the placebo-treated children. The incidence of cerebral palsy was 10\% in the dexamethasone group and 22\% in the placebo group. Minor developmental delay was found in 42\% of dexamethasone-treated and in 53\% of placebo-treated children. Our follow-up results indicate that the beneficial effect of prenatal glucocorticoid treatment on cerebral complications (intraventricular haemorrhage or periventricular leucomalacia) demonstrated during the neonatal period may be followed by a lower incidence of cerebral palsy in surviving premature children.

Tags

Users

  • @ar0berts

Comments and Reviews